HLA-DR Antikörper
-
- Target Alle HLA-DR Produkte
- HLA-DR
-
Reaktivität
- Pavian, Cynomolgus, Rhesusaffen, Hund, Kaninchen
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser HLA-DR Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS)
- Marke
- BD Pharmingen™
- Produktmerkmale
-
Reacts with a monomorphic epitope of major histocompatibility Class II HLA-DR antigens expressed on B cells, activated T cells, and antigen presenting cells. Detects the αβ complex and not the isolated chains. This antibody fixes complement. This antibody is routinely tested by flow cytometric analysis. Other applications were tested during antibody development only or reported in the literature. Profile of peripheral blood lymphocytes analyzed on a FACScan
BD Pharmingen™ Purified Mouse Anti-Human HLA-DR - Purified - Clone TU36 - Isotype Mouse IgG2b, κ - Reactivity Bab, Cyno, Rhe, Dog, Rab - 0.1 mg - Aufreinigung
- The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
- Klon
- TU36
- Isotyp
- IgG2b kappa
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.5 mg/mL
- Buffer
- Aqueous buffered solution containing ≤0.09 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store undiluted at 4°C.
-
-
Analysis by sequential immunoprecipitations of the specificities of the monoclonal antibodies TU22,34,35,36,37,39,43,58 and YD1/63.HLK directed against human HLA class II antigens." in: Immunobiology, Vol. 171, Issue 1-2, pp. 77-92, (1986) (PubMed).
: "Dissection of human allostimulatory determinants with cloned T cells: stimulation inhibition by monoclonal antibodies TU22, 34, 35, 36, 37, 39, 43, and 58 against distinct human MHC class II ..." in: Human immunology, Vol. 12, Issue 3, pp. 165-76, (1985) (PubMed).
: "
-
Analysis by sequential immunoprecipitations of the specificities of the monoclonal antibodies TU22,34,35,36,37,39,43,58 and YD1/63.HLK directed against human HLA class II antigens." in: Immunobiology, Vol. 171, Issue 1-2, pp. 77-92, (1986) (PubMed).
-
- Target
- HLA-DR
- Andere Bezeichnung
- HLA-DR (HLA-DR Produkte)
-